Daliresp (DA-li-resp, roflumilast), a new oral tab for people with severe chronic obstructive pulmonary disease (COPD)

July 2011

You'll hear about Daliresp (DA-li-resp, roflumilast), a new oral tab for people with severe chronic obstructive pulmonary disease (COPD).

COPD is a lung disease that makes it hard to breathe. Many patients use inhalers to open up airways and reduce inflammation in the lungs...to prevent "flare-ups" or worsening of the disease.

Daliresp is the first oral med that helps prevent flare-ups.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote